178 related articles for article (PubMed ID: 21689431)
1. Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice.
Imhof AK; Glück L; Gajda M; Bräuer R; Schaible HG; Schulz S
Arthritis Res Ther; 2011 Jun; 13(3):R97. PubMed ID: 21689431
[TBL] [Abstract][Full Text] [Related]
2. Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.
Donate PB; Cunha TM; Verri WA; Junta CM; Lima FO; Vieira SM; Peres RS; Bombonato-Prado KF; Louzada P; Ferreira SH; Donadi EA; Passos GA; Cunha FQ
Inflamm Res; 2012 Apr; 61(4):337-48. PubMed ID: 22249931
[TBL] [Abstract][Full Text] [Related]
3. Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: inhibition by endothelin receptor antagonists.
De-Melo JD; Tonussi CR; D'Orléans-Juste P; Rae GA
Pain; 1998 Sep; 77(3):261-269. PubMed ID: 9808351
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor antagonists alleviate blood-brain barrier disruption and cerebral edema in a mouse model of traumatic brain injury: A comparison between bosentan and ambrisentan.
Michinaga S; Inoue A; Yamamoto H; Ryu R; Inoue A; Mizuguchi H; Koyama Y
Neuropharmacology; 2020 Sep; 175():108182. PubMed ID: 32561219
[TBL] [Abstract][Full Text] [Related]
5. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.
Imhof AK; Glück L; Gajda M; Lupp A; Bräuer R; Schaible HG; Schulz S
Arthritis Rheum; 2011 Aug; 63(8):2352-62. PubMed ID: 21506098
[TBL] [Abstract][Full Text] [Related]
6. Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1.
Conte Fde P; Barja-Fidalgo C; Verri WA; Cunha FQ; Rae GA; Penido C; Henriques Md
J Leukoc Biol; 2008 Sep; 84(3):652-60. PubMed ID: 18515326
[TBL] [Abstract][Full Text] [Related]
7. Bladder endothelin-1 receptor binding of bosentan and ambrisentan.
Osano A; Yokoyama Y; Hayashi H; Itoh K; Okura T; Deguchi Y; Ito Y; Yamada S
J Pharmacol Sci; 2014; 124(1):86-91. PubMed ID: 24389822
[TBL] [Abstract][Full Text] [Related]
8. Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.
Serafim KG; Navarro SA; Zarpelon AC; Pinho-Ribeiro FA; Fattori V; Cunha TM; Alves-Filho JC; Cunha FQ; Casagrande R; Verri WA
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1211-21. PubMed ID: 26246053
[TBL] [Abstract][Full Text] [Related]
9. Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
Gatfield J; Mueller Grandjean C; Sasse T; Clozel M; Nayler O
PLoS One; 2012; 7(10):e47662. PubMed ID: 23077657
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 receptors in rat tissues: characterization by bosentan, ambrisentan and CI-1020.
Yokoyama Y; Osano A; Hayashi H; Itoh K; Okura T; Deguchi Y; Ito Y; Yamada S
Biol Pharm Bull; 2014; 37(3):461-5. PubMed ID: 24583865
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.
Weiss J; Herzog M; Haefeli WE
Eur J Pharmacol; 2011 Jun; 660(2-3):298-304. PubMed ID: 21501604
[TBL] [Abstract][Full Text] [Related]
12. Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.
Weiss J; Theile D; Spalwisz A; Burhenne J; Riedel KD; Haefeli WE
Biochem Pharmacol; 2013 Jan; 85(2):265-73. PubMed ID: 23219525
[TBL] [Abstract][Full Text] [Related]
13. The role of interleukin-1β in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis.
Ebbinghaus M; Uhlig B; Richter F; von Banchet GS; Gajda M; Bräuer R; Schaible HG
Arthritis Rheum; 2012 Dec; 64(12):3897-907. PubMed ID: 22933159
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin.
Knobloch J; Feldmann M; Wahl C; Jungck D; Behr J; Stoelben E; Koch A
J Pharmacol Exp Ther; 2013 Aug; 346(2):290-9. PubMed ID: 23720457
[TBL] [Abstract][Full Text] [Related]
15. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
Lee TM; Chen CC; Lin MS; Chang NC
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury.
Kazimoglu H; Uysal E; Dokur M; Gurer AO; Batcioglu K; Uyumlu BA; Petekkaya E; Karadag M
Bratisl Lek Listy; 2020; 121(8):547-553. PubMed ID: 32726116
[TBL] [Abstract][Full Text] [Related]
17. Functional estimation of endothelin-1 receptor antagonism by bosentan, macitentan and ambrisentan in human pulmonary and radial arteries in vitro.
Angus JA; Soeding PF; Hughes RJA; Wright CE
Eur J Pharmacol; 2017 Jun; 804():111-116. PubMed ID: 28300593
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism.
Knobloch J; Lin Y; Konradi J; Jungck D; Behr J; Strauch J; Stoelben E; Koch A
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):114-27. PubMed ID: 23590298
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target.
Boettger MK; Hensellek S; Richter F; Gajda M; Stöckigt R; von Banchet GS; Bräuer R; Schaible HG
Arthritis Rheum; 2008 Aug; 58(8):2368-78. PubMed ID: 18668541
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
